sever
acut
respiratori
syndrom
sar
epidem
start
late
swiftli
spread
across
contin
mortal
rate
around
although
epidem
eventu
control
implement
strict
quarantin
measur
continu
need
investig
sar
coronaviru
sarscov
develop
intervent
reemerg
numer
studi
shown
neutral
antibodi
viru
found
patient
infect
sarscov
within
day
upon
onset
ill
last
sever
month
contrast
littl
data
kinet
cell
respons
sarscov
infect
littl
known
role
recoveri
process
howev
recent
studi
mice
suggest
import
cell
viral
clearanc
sarscov
infect
moreov
grow
number
studi
investig
memori
cell
respons
recov
sar
patient
review
cover
avail
literatur
emerg
import
cell
respons
sarscov
infect
particularli
map
cytotox
lymphocyt
ctl
epitop
longev
polyfunction
human
leukocyt
antigen
hla
associ
well
potenti
implic
treatment
vaccin
develop
sever
acut
respiratori
syndrom
sar
first
emerg
guangdong
china
late
infect
peopl
countri
across
contin
accord
world
health
organ
fatal
rate
sar
outbreak
estim
infect
healthcar
worker
caretak
account
major
sar
epidem
offici
control
juli
implement
strict
isol
patient
sometim
epidem
novel
coronaviru
sar
coronaviru
sarscov
identifi
caus
agent
molecular
epidemiolog
show
least
two
strain
sarscov
infect
patient
hong
kong
suggest
viru
jump
anim
sourc
human
two
separ
occas
later
report
two
laboratori
identifi
viru
resid
chines
horsesho
bat
genet
similar
human
sarscov
pinpoint
horsesho
bat
like
natur
reservoir
sarscov
inde
case
reemerg
sarscov
rule
coronavirus
divers
group
larg
envelop
positivestrand
rna
virus
order
niloviral
famili
coronavirida
genu
coronaviru
typic
caus
respiratori
enter
diseas
human
anim
use
open
read
frame
orf
sequenc
sarscov
categor
subgroup
group
ii
coronavirus
kb
polyadenyl
positivestrand
rna
genom
genom
organ
typic
coronaviru
first
two
orf
encod
viral
replicas
requir
process
viral
cystein
proteinas
yield
function
membranebound
replicas
complex
group
nonstructur
protein
nsp
although
function
nsp
investig
known
mani
other
still
requir
character
review
cheng
et
al
sarscov
genom
encod
four
structur
protein
spike
envelop
e
membran
nucleocaspid
n
addit
set
uniqu
accessori
protein
name
orf
also
found
function
n
protein
pack
rna
helic
nucleocapsid
protein
form
characterist
project
virion
surfac
attach
entri
host
cell
togeth
n
e
control
assembl
virion
present
signific
homolog
found
accessori
protein
viral
protein
coronavirus
fact
found
dispens
viru
replic
cell
cultur
despit
contribut
viral
pathogenesi
neutral
antibodi
sarscov
found
patient
anim
infect
sarscov
block
viral
entri
bind
glycoprotein
besid
humor
respons
role
cell
viral
infect
known
import
whilst
neutral
antibodi
prevent
viral
entri
bodi
also
requir
sarscov
specif
helper
cell
develop
specif
antibodi
similarli
cytotox
cell
import
recognit
kill
infect
cell
particularli
lung
infect
individu
despit
increas
number
report
investig
memori
cell
respons
recov
sar
patient
lack
data
describ
kinet
cell
respons
sarscov
infect
review
focu
memori
cell
studi
possibl
implic
treatment
vaccin
develop
easi
refer
cell
epitop
identifi
summar
tabl
amongst
sarscov
structur
protein
protein
found
elicit
neutral
antibodi
major
immunodomin
epitop
found
residu
use
onlin
databas
verif
bind
assay
first
two
hlaa
cell
epitop
identifi
protein
sarscov
immunogen
elicit
high
ifncspecif
cell
respons
patient
recov
sar
comparison
homolog
peptid
elicit
signific
respons
third
ctl
epitop
also
known
report
shortli
anoth
group
peptid
abl
induc
ctl
respons
hlaa
transgen
mice
immun
peptid
load
dendrit
cell
dc
time
abl
gener
peptidespecif
ctl
peripher
blood
mononuclear
cell
pbmc
healthi
human
donor
group
also
show
heat
inactiv
sarscov
particl
elicit
ctl
respons
three
epitop
patient
pbmc
one
year
postinfect
interestingli
healthi
individu
without
contact
histori
sarscov
also
exhibit
respons
pbmc
exhibit
lower
cytotox
activ
cytokin
releas
compar
recov
sar
patient
cell
epitop
identifi
includ
found
domain
found
domain
epitop
found
immunogen
abl
induc
strong
ifnc
product
pbmc
recov
sar
patient
time
hlaa
transgen
mice
immun
dna
vaccin
encod
protein
abl
induc
signific
peptidespecif
respons
studi
hlaa
restrict
epitop
also
known
first
identifi
base
hlaa
bind
peptid
proteosom
cleavag
predict
system
found
capabl
induc
specif
ctl
pbmc
healthi
individu
well
transgen
mice
immun
dna
vaccin
suggest
may
alreadi
sarscovspecif
ctl
precursor
cell
within
tcell
repertoir
healthi
individu
anim
studi
use
mice
prime
intramuscularli
dna
vaccin
boost
subcutan
hlaa
restrict
peptid
dna
vaccin
alon
elicit
antigenspecif
cell
respons
fact
one
recent
studi
show
primeboost
immun
transgen
mice
hlaa
peptid
togeth
cpg
oligodeoxynucleotid
odn
could
significantli
enhanc
frequenc
peptidespecif
cell
taken
togeth
protein
capabl
induc
neutral
antibodi
also
contain
sever
immunogen
cell
epitop
epitop
found
either
domain
protein
therefor
consid
sarscov
vaccin
develop
besid
glycoprotein
persist
high
level
antin
protein
antibodi
cell
respons
also
found
sarsrecov
individu
year
postinfect
coronavirus
protect
effect
found
confer
nspecif
cell
use
similar
approach
hla
peptid
bind
predict
algorithm
valid
bind
assay
tsao
cell
immun
respons
sar
coronaviru
infect
hlj
oh
et
al
et
al
identifi
sever
hlaa
restrict
epitop
n
protein
peptid
show
could
induc
specif
ctl
respons
transgen
mice
immun
n
protein
peptid
cpg
odn
addit
peptid
abl
stimul
recal
cell
respons
pbmc
recov
sar
patient
numer
attempt
screen
ctl
epitop
n
protein
use
overlap
peptid
span
entir
n
protein
one
studi
use
pbmc
recov
sar
patient
year
postinfect
reveal
major
domin
antigen
site
n
protein
lie
ctermin
region
amino
acid
least
differ
cell
epitop
found
region
pbmc
stimul
pool
overlap
n
peptid
vitro
follow
ifnc
enzymelink
immunosorb
spot
elispot
assay
use
approach
anoth
group
identifi
potenti
ctl
epitop
posit
n
protein
recent
also
identifi
domin
respons
sarsrecov
patient
year
postinfect
respons
observ
cohort
recov
sar
patient
similarli
comprehens
studi
cell
respons
sarscov
protein
conduct
li
et
al
show
sar
subject
gave
posit
cell
respons
peptid
identifi
recogn
epitop
n
protein
exact
epitop
map
group
indic
ctl
epitop
mer
restrict
hlab
pbmc
healthi
individu
transduc
becom
n
peptidespecif
cell
one
first
anim
studi
conduct
monkey
adenoviralbas
vector
use
test
efficaci
n
protein
monkey
inject
intramuscularli
adenoviralbas
vector
express
codonoptim
domain
n
protein
domain
protein
found
induc
strong
humor
respons
n
protein
elicit
high
frequenc
ifncproduc
cell
determin
use
n
peptid
antigen
elispot
assay
first
indic
n
protein
could
good
vaccin
candid
cellmedi
cell
respons
phenomenon
also
found
mice
dna
vaccin
encod
n
protein
elicit
good
cell
respons
mice
intramuscularli
immun
n
protein
pcdnafn
vector
show
high
antibodi
titr
ctl
activ
inject
use
balbc
mice
two
group
show
dna
vaccin
encod
n
protein
alon
could
elicit
cell
prolifer
ifnc
releas
delayedtyp
hypersensit
dth
vivo
cytotox
cell
activ
experi
report
enhanc
cell
respons
calreticulin
crt
link
dna
vaccin
use
dna
vaccin
perform
addit
chemic
adjuv
levamisol
synthet
n
peptid
coupl
surfac
liposom
also
report
enhanc
cell
respons
synthet
n
peptid
induc
ctl
respons
mice
also
abl
clear
vaccinia
virusexpress
sarscov
epitop
challeng
summari
sever
differ
studi
identifi
immunogen
region
amino
acid
n
protein
contain
cell
epitop
howev
date
epitop
character
detail
epitop
restrict
hlab
studi
cell
respons
sarscov
protein
nonetheless
anim
studi
use
dna
vaccin
suggest
protein
may
induc
cell
respons
albeit
lesser
degre
n
protein
yang
et
al
demonstr
possibl
induc
recal
cell
respons
pbmc
sar
patient
recov
year
use
overlap
peptid
span
entir
protein
studi
four
human
cell
immunodomin
peptid
subsequ
identifi
similarli
li
et
al
also
report
sar
subject
cell
respons
peptid
region
largest
accessori
protein
sarscov
protein
amino
acid
howev
li
et
al
report
demonstr
cell
respons
protein
protein
peptid
one
three
frequent
recogn
cell
epitop
identifi
studi
similar
result
report
li
et
al
data
show
protein
peptid
abl
elicit
respons
interestingli
mice
immun
dna
vaccin
shown
high
level
humor
respons
well
respons
observ
indic
accessori
protein
immunogen
abl
induc
cell
respons
although
cell
respons
could
observ
protein
current
studi
seem
suggest
protein
immunogen
comparison
cell
epitop
identifi
may
play
import
role
recoveri
primari
sarscov
infect
vaccin
develop
date
one
studi
investig
cell
respons
whole
sarscov
human
studi
pbmc
postinfect
patient
show
cell
respons
eight
replicas
n
e
fourteen
sarscov
protein
test
use
overlap
peptid
span
entir
sarscov
genom
cell
respons
elicit
structur
protein
protein
induc
domin
respons
fact
three
commonli
recogn
cell
epitop
one
found
two
protein
latter
report
studi
although
cell
respons
observ
studi
frequenc
magnitud
cell
respons
greater
cell
respons
howev
cell
found
similar
central
memori
phenotyp
separ
studi
peng
et
al
show
nspecif
cell
central
memori
wherea
cell
effector
memori
phenotyp
similar
observ
made
mspecif
cell
whilst
sspecif
cell
report
effector
memori
phenotyp
use
peptid
four
sarscov
structur
protein
analysi
memori
cell
respons
recov
sar
patient
four
year
postinfect
reveal
cell
produc
ifnc
support
li
et
al
studi
fan
et
al
also
found
memori
cell
produc
tnfa
ifnc
except
one
patient
also
observ
peptid
induc
highest
percentag
ifnc
produc
cell
interestingli
frequenc
polyfunct
cell
cell
produc
multipl
cytokin
higher
individu
sever
sar
infect
moder
sever
patient
hand
differ
moder
sever
sever
patient
nonetheless
proport
cell
found
produc
tnfa
degranul
detect
sinc
polyfunct
cell
associ
better
control
human
immunodefici
viru
hiv
infect
vaccin
efficaci
character
cytokin
profil
sarsspecif
cell
recent
studi
summari
find
shown
figur
observ
major
cell
produc
ifnc
tnfa
small
percentag
cell
also
simultan
produc
inflammatori
cytokin
macrophag
inflammatori
protein
mip
mip
granulocytemacrophag
colonystimul
factor
gmcsf
major
cell
produc
ifnc
tnfa
mip
mip
alon
combin
small
percentag
produc
ifnc
tnfa
move
forward
clone
b
cell
receptor
tcr
chain
one
immunodomin
ctl
epitop
n
protein
amino
acid
sarscov
specif
cell
use
redirect
specif
lymphocyt
healthi
subject
lack
sarscov
specif
memori
cell
tcrredirect
cell
found
possess
cytokin
product
profil
similar
sarscov
specif
memori
cell
recov
sar
patient
mention
thu
propos
cell
may
potenti
therapeut
treatment
life
threaten
infect
despit
numer
report
describ
elev
inflammatori
cytokin
primari
infect
patient
review
zhu
et
al
known
cytokin
benefici
contribut
pathogen
infect
moreov
current
report
confirm
protect
effect
cell
primari
sarscov
infect
human
fact
research
area
hamper
lack
systemat
sampl
collect
sar
outbreak
last
rel
short
period
week
sinc
second
major
outbreak
sar
protect
effect
memori
cell
respons
recov
sar
patient
known
nevertheless
phenotyp
cytokin
profil
cell
recov
individu
indic
possibl
protect
effect
cell
respons
initi
infect
subsequ
infect
associ
certain
hla
genotyp
increas
resist
abil
clear
viral
infect
report
hepat
c
viru
hcv
human
papillomaviru
studi
although
earlier
studi
done
sar
patient
taiwan
hong
kong
suggest
hlab
hlacw
hladr
allel
highli
associ
sar
infect
diseas
develop
investig
requir
literatur
sar
individu
hong
kong
show
hlab
hladr
confer
factor
suscept
resist
sar
infect
respect
agreement
studi
taiwanes
cohort
sar
patient
found
hlacw
hladr
associ
resist
sar
infect
observ
suggest
import
role
hladr
viral
diseas
progress
enhanc
function
helper
cell
similarli
observ
cell
respons
n
protein
restrict
hlab
subtyp
unpublish
data
thu
point
possibl
role
hlab
subtyp
viral
immun
among
hla
class
gene
hlab
known
polymorph
associ
protect
role
hiv
hcv
acut
influenza
infect
conclus
current
antivir
therapi
yet
proven
use
sar
attempt
test
potenti
antisar
agent
use
antivir
antibodi
entri
inhibitor
proteinas
inhibitor
calpain
inhibitor
ribavirin
nucleosid
analogu
interferon
short
interf
rna
riddl
contradictori
report
differ
laboratori
lack
clinic
trial
also
prevent
reach
conclus
agreement
effect
antisar
strategi
review
weiss
et
al
nevertheless
human
convalescentphas
plasma
seem
shorten
hospit
without
advers
effect
administ
immunotherapi
sar
patient
earli
cours
infect
find
recov
sar
patient
higher
sustain
level
neutral
antibodi
compar
succumb
diseas
monoclon
antibodi
passiv
immun
also
obtain
use
phagedisplay
antibodi
librari
immort
b
cell
convalesc
sar
patient
although
still
known
whether
natur
acquir
immun
respons
confer
protect
reinfect
sarscov
vaccin
like
effect
way
provid
protect
futur
reemerg
sarscov
sever
strategi
vaccin
develop
includ
dna
vaccin
inactiv
whole
viru
vaccin
viruslik
particl
recombin
viru
vector
vaccin
recombin
protein
vaccin
sarscov
vaccin
elicit
neutral
antibodi
believ
protect
describ
cell
may
also
play
import
role
viral
clearanc
primari
sarscov
infect
zhao
et
al
suggest
ineffici
immun
activ
poor
virusspecif
cell
respons
underlay
sever
diseas
sarscov
infect
mice
recent
report
show
virusspecif
cell
necessari
suffici
viru
clearanc
protect
clinic
diseas
mouseadapt
sarscov
virusinfect
mice
addit
cell
senesc
mous
model
found
play
import
role
viral
clearanc
primari
infect
sarscov
human
sarscovspecif
memori
cell
found
persist
peripher
blood
sar
patient
year
figur
diagram
show
cytokin
profil
cell
sar
recov
patient
big
small
arrow
indic
major
minor
popul
cell
produc
cytokin
indic
respect
cell
immun
respons
sar
coronaviru
infect
hlj
oh
et
al
postinfect
despit
lack
specif
memori
b
cell
respons
patient
seem
suggest
sarscovspecif
cell
respons
could
persist
longer
thu
indic
cellmedi
immun
respons
import
protect
reinfect
studi
suggest
cell
may
play
crucial
role
clearanc
sarscov
therefor
need
detail
character
cell
respons
sarscov
develop
futur
vaccin
candid
final
import
note
cell
play
protect
patholog
role
infect
case
mousehepat
viru
mhv
increas
morbid
mortal
infect
mice
associ
memori
cell
although
direct
evid
shown
sarscovspecif
cell
respons
contribut
immunopatholog
sar
question
need
address
cell
immun
respons
sar
coronaviru
infect
hlj
oh
et
al
